Details of the Target
General Information of Target
Target ID | LDTP11009 | |||||
---|---|---|---|---|---|---|
Target Name | Opiorphin prepropeptide (OPRPN) | |||||
Gene Name | OPRPN | |||||
Gene ID | 58503 | |||||
Synonyms |
BPLP; PROL1; Opiorphin prepropeptide; Basic proline-rich lacrimal protein; Proline-rich protein 1; PRL1) [Cleaved into: Opiorphin] |
|||||
3D Structure | ||||||
Sequence |
MAQRGGARRPRGDRERLGSRLRALRPGREPRQSEPPAQRGPPPSGRPPARSTASGHDRPT
RGAAAGARRPRMKKKTRRRSTRSEELTRSEELTLSEEATWSEEATQSEEATQGEEMNRSQ EVTRDEESTRSEEVTREEMAAAGLTVTVTHSNEKHDLHVTSQQGSSEPVVQDLAQVVEEV IGVPQSFQKLIFKGKSLKEMETPLSALGIQDGCRVMLIGKKNSPQEEVELKKLKHLEKSV EKIADQLEELNKELTGIQQGFLPKDLQAEALCKLDRRVKATIEQFMKILEEIDTLILPEN FKDSRLKRKGLVKKVQAFLAECDTVEQNICQETERLQSTNFALAE |
|||||
Target Bioclass |
Other
|
|||||
Family |
PROL1/PROL3 family
|
|||||
Subcellular location |
Secreted
|
|||||
Function |
Opiorphin is an endogenous inhibitor of neprilysin and aminopeptidase N. Inhibits the breakdown of substance P, Mca-BK2 and Met-enkephalin by neprilysin in vitro with IC(50) values of 29 uM, 33 uM and 33 uM respectively. Inhibits the breakdown of Ala-pNA by aminopeptidase N in vitro with an IC(50) of 65 uM. Has a potent analgesic effect when administered to rats by intravenous injection.
|
|||||
Uniprot ID | ||||||
Ensemble ID | ||||||
HGNC ID |
Probe(s) Labeling This Target
PAL-AfBPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
C218 Probe Info |
![]() |
34.54 | LDD1892 | [1] | |
C221 Probe Info |
![]() |
15.67 | LDD1895 | [1] |